Materiały źródłowe

• #1 Adrenoleukodystrophy – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK562328/

  Adrenoleukodystrophy is a rare genetic peroxisomal disorder characterized by the abnormal metabolism of very long-chain fatty acids (VLCFAs) due to mutations in the ABCD1 gene. This leads to the accumulation of VLCFAs, particularly affecting the brain, spinal cord, adrenal glands, and testes. […] Symptoms typically include progressive neurological dysfunction and adrenal insufficiency, which is managed with glucocorticoid and mineralocorticoid replacement therapies. Hematopoietic stem cell transplantation (HSCT) remains the primary therapeutic option for early-stage adrenoleukodystrophy, offering the best chance to halt disease progression and improve outcomes. […] Clinical manifestations of adrenoleukodystrophy vary widely but usually include the combination of progressive neurological dysfunction and adrenal insufficiency.

• #2 Adrenoleukodystrophy – Wikipedia

  https://en.wikipedia.org/wiki/Adrenoleukodystrophy

  Adrenoleukodystrophy (ALD) is a disease linked to the X chromosome. It is a result of fatty acid buildup caused by failure of peroxisomal fatty acid beta oxidation which results in the accumulation of very long chain fatty acids in tissues throughout the body. The long chain fatty acid buildup causes damage to the myelin sheath of the neurons of the brain, resulting in seizures and hyperactivity. Other symptoms include problems in speaking, listening, and understanding verbal instructions. […] Approximately one third of male ALD patients will present with the childhood cerebral form of the disease, which is the most severe form. It is characterized by normal development in early childhood, followed by rapid degeneration to a vegetative state. The other forms of ALD vary in timing of onset and in clinical severity, ranging from adrenal insufficiency alone to progressive paraparesis in early adulthood.

• #3 Cerebral Adrenoleukodystrophy – Child Neurology Foundation

  https://www.childneurologyfoundation.org/disorder/cerebral-adrenoleukodystrophy/

  Cerebral ALD is a progressive neurological disorder. Severe forms can eventually lead to: […] Cerebral ALD typically presents in early childhood. Boys start showing symptoms between 4 and 10 years of age. […] As the disease progresses, children end up in a vegetative state. They lose all neurological function. They often pass away within 1 to 5 years of symptom onset. […] If untreated or when diagnosis is delayed, cerebral ALD is rapidly progressive. In these cases, within 1 to 5 years of diagnosis, children with ALD: […] It is not possible to outgrow cerebral ALD. Cerebral ALD causes progressive degeneration of the nervous system. It can lead to death within 5 to 10 years of diagnosis unless stem-cell transplantation is performed early. […] Short term studies have shown that early stem-cell transplantation is important. Early transplantation can mean:

• #4 X-Linked Adrenoleukodystrophy: Symptoms, Causes, and Treatment

  https://www.healthline.com/health/x-linked-adrenoleukodystrophy

  About 35% of males develop neurological symptoms between the ages of 3 and 10 years. Symptoms rarely develop before the ages of 2.5 to 3 years. […] Signs and symptoms may include: slow regression of previously acquired movement skills, behavioral differences, like attention deficit hyperactivity disorder (ADHD), learning difficulties, impairment of mental processes, decline in school performance, inattentiveness, difficulty understanding speech, difficulty reading or understanding written words, worsening handwriting. […] Many children also have Addisons disease, which is characterized by the underproduction of cortisol and aldosterone by the adrenal glands. […] Childhood ALD typically progresses to a vegetative state within 2 to 3 years from the onset of neurological symptoms. […] Adrenomyeloneuropathy is a form of X-ALD that onsets from the late 20s to middle age. It affects almost all males with the ABCD1 gene mutation who dont develop childhood disease.

• #5 ALD: Adrenoleukodystrophy, Disease, X-Linked

  https://my.clevelandclinic.org/health/diseases/6030-adrenoleukodystrophy-ald

  Adrenoleukodystrophy, ALD, is a genetic disorder connected to the X chromosome. It affects the nervous system and adrenal glands. Symptoms of ALD often include behavioral and cognitive changes. ALD is a progressive disease. Treatments aim to slow the progression and improve peoples quality of life. […] ALD symptoms often appear between the ages of 3 and 10, though they can start later in life. The childhood form of ALD is the most severe. […] Early symptoms include behavioral problems, such as attention deficit hyperactivity disorder (ADHD) and learning disabilities. Cognitive deficits, or problems with thinking and processing new information. Children may space out at school. They may have trouble with reading, handwriting and solving spatial problems. Regression, when children lose skills.

• #6 Adrenoleukodystrophy (ALD): Causes, Types, Symptoms, Prognosis

  https://www.webmd.com/brain/what-is-adrenoleukodystrophy

  Symptoms of the cerebral form of ALD, also called cerebral ALD or CALD, begin to appear between the ages of 4 and 10. More common symptoms impact behavior and learning and include: Memory issues, Learning disabilities, Withdrawal or aggressiveness, Vision and hearing problems, Difficulty walking. […] If not treated, cerebral ALD can lead to more severe symptoms and quickly worsen, potentially leading to loss of consciousness and early death. […] About 45% of people with ALD have this type. Its the most severe form of ALD. Symptoms often start between ages of 4 and 10 and include: Attention deficit disorder (ADD), Problems with vision, hearing, and motor function, Behavior problems, Hyperactivity, Getting tired easily, Clumsiness, Low blood sugar, Eye pain, Migraines, Viral infections that keep coming back, Skin that looks tanned or bronzed.

• #7 Pediatric adrenoleukodystrophy (ALD) – Children’s Health Endocrinology

  https://www.childrens.com/specialties-services/conditions/adrenoleukodystrophy

  Cerebral ALD is a severe form of adrenoleukodystrophy that damages the myelin sheath and prohibits the brain from working properly. This form only affects boys, with symptoms usually starting between ages 2 and 10. […] The symptoms of adrenoleukodystrophy depend on the type your child develops. […] Symptoms of cerebral ALD include: Aggressive behavior, Behavior problems, Difficulty reading and writing, Difficulty swallowing, Hearing problems, Memory problems, Poor coordination, Problems speaking, Seizures, Vision problems.

• #8 Adrenoleukodystrophy (ALD) | Boston Children’s Hospital

  https://www.childrenshospital.org/conditions/adrenoleukodystrophy-ald

  Adrenoleukodystrophy (ALD) is a rare genetic condition that affects males and females differently. In childhood, boys are primarily affected. Girls are not typically affected, though they may develop symptoms as adults. […] In CALD, VLCFAs build up in the brain and can destroy the protective myelin sheath around the nerve cells that control our muscles, interfering with their ability to communicate with the brain. Untreated, CALD progresses rapidly and can cause permanent cognitive and motor disabilities and death, usually within four to eight years. […] Boys with CALD usually begin showing symptoms between ages 4 and 10. The most common symptoms include behavioral problems, withdrawal or aggression, poor memory, poor school performance, and difficulty reading, writing, and understanding speech.

• #9 Adrenoleukodystrophy | Children’s Hospital of Philadelphia

  https://www.chop.edu/conditions-diseases/adrenoleukodystrophy

  Adrenoleukodystrophy (ALD) is a rare X-linked genetic disorder that affects the brain and adrenal glands (small glands that produce important hormones in the body). This condition causes accumulation of harmful fatty acids in the blood stream, resulting in damage to myelin in the brain and spinal cord, as well as the adrenal glands. Myelin is the insulation around our nerves. The nervous system needs myelin to function properly. […] Symptoms usually begin in early childhood and manifest with changes to behavior, seizures or motor skills. Without treatment, children can lose their ability to move and think. Untreated, CALD eventually causes profound loss of skills or death within a few years of showing symptoms. […] Symptoms of CALD usually begin around ages 4 to 8 in a percentage of boys affected by ALD. Symptoms include: behavioral or learning deficits, deterioration in handwriting skills, poor school performance, difficulty understanding speech, difficulty reading, clumsiness.

• #10 Adrenoleukodystrophy (ALD): Causes, Types, Symptoms, Prognosis

  https://www.webmd.com/brain/what-is-adrenoleukodystrophy

  Symptoms of the cerebral form of ALD, also called cerebral ALD or CALD, begin to appear between the ages of 4 and 10. More common symptoms impact behavior and learning and include: Memory issues, Learning disabilities, Withdrawal or aggressiveness, Vision and hearing problems, Difficulty walking. […] If not treated, cerebral ALD can lead to more severe symptoms and quickly worsen, potentially leading to loss of consciousness and early death. […] About 45% of people with ALD have this type. Its the most severe form of ALD. Symptoms often start between ages of 4 and 10 and include: Attention deficit disorder (ADD), Problems with vision, hearing, and motor function, Behavior problems, Hyperactivity, Getting tired easily, Clumsiness, Low blood sugar, Eye pain, Migraines, Viral infections that keep coming back, Skin that looks tanned or bronzed.

• #11 ALD: Adrenoleukodystrophy, Disease, X-Linked

  https://my.clevelandclinic.org/health/diseases/6030-adrenoleukodystrophy-ald

  As the disease progresses, symptoms include vision problems, hearing loss, trouble walking, weak and stiff limbs, convulsions and seizures, dementia, trouble eating, and vomiting. Eventually, children lose most of their neurological abilities. They lose sight, hearing and voluntary movements. As the disease progresses, children end up in a vegetative state. They often pass away within two to three years of the neurological symptoms starting. […] Symptoms of adrenal insufficiency include fatigue, weight loss, nausea and vomiting, digestive problems, feeling weak, headaches in the morning, hypotension, hypoglycemia, and hyperpigmented skin, when the skin darkens unrelated to sun exposure. […] Symptoms include spasticity (muscle stiffness), weakness or paralysis of the lower limbs, ataxia, neurological conditions affecting movement, numbness and pain, erectile dysfunction, bowel incontinence, bladder control problems, and premature baldness.

• #12 Adrenoleukodystrophy (ALD) | Boston Children’s Hospital

  https://www.childrenshospital.org/conditions/adrenoleukodystrophy-ald

  As the condition progresses, other signs and symptoms of CALD may include vision problems, seizures, difficulty swallowing, deafness, poor coordination, and inability to speak or respond. […] Without treatment, CALD can progress rapidly, typically leading to a vegetative state or death within a few years.

• #13 Adrenoleukodystrophy Information | Mount Sinai – New York

  https://www.mountsinai.org/health-library/diseases-conditions/adrenoleukodystrophy

  Adrenoleukodystrophy (ALD) describes several closely related disorders that disrupt the breakdown of certain fats. These disorders are often passed down (inherited) in families. […] Childhood cerebral type symptoms include: Changes in muscle tone, especially muscle spasms and uncontrolled movements, Crossed eyes, Handwriting that gets worse, Difficulty at school, Difficulty understanding what people are saying, Hearing loss, Hyperactivity, Worsening nervous system damage, including coma, decreased fine motor control, and paralysis, Seizures, Swallowing difficulties, Visual impairment or blindness. […] The childhood form of X-linked ALD is a progressive disease. It leads to a long-term coma (vegetative state) about 2 years after nervous system symptoms develop. The child can live in this condition for as long as 10 years until death occurs. […] The other forms of this disease are milder.

• #14 Cerebral Adrenoleukodystrophy – Child Neurology Foundation

  https://www.childneurologyfoundation.org/disorder/cerebral-adrenoleukodystrophy/

  The childhood form is known as cerebral ALD. Cerebral ALD is the more severe form of ALD. In cerebral ALD, expect: […] Symptoms beginning between 4 and 10 years of age […] Rapid progression […] Eventual symptoms to include: […] Difficulty walking […] Learning disability […] Inability to perform activities of daily living […] Seizures.

• #15 Adrenoleukodystrophy | Children’s Hospital of Philadelphia

  https://www.chop.edu/conditions-diseases/adrenoleukodystrophy

  As the disease progresses, symptoms include visual disturbances, loss of hearing, seizures, and trouble moving or speaking, eventually leading to loss of all body functions over a few years. […] Every child identified with ALD through the newborn screening must receive standardized neurologic monitoring throughout childhood that includes blood work and brain MRIs. This allows clinicians to see changes in the brain before the child shows any physical symptoms. This also allows treatment of adrenal insufficiency, which can be life threatening. If the care team sees anything concerning, they can provide personalized intervention immediately before a child has permanent injury to their brain. Targeted treatment of CALD has the best outcome when performed on an individual before symptoms are clinically visible. […] In recent clinical trials, gene therapy has shown promising results in stabilizing the progression of the disease in boys with early-stage CALD. However, additional research is necessary to assess its long-term effectiveness and safety.

• #16 Adrenoleukodystrophy Information | Mount Sinai – New York

  https://www.mountsinai.org/health-library/diseases-conditions/adrenoleukodystrophy

  Adrenoleukodystrophy (ALD) describes several closely related disorders that disrupt the breakdown of certain fats. These disorders are often passed down (inherited) in families. […] Childhood cerebral type symptoms include: Changes in muscle tone, especially muscle spasms and uncontrolled movements, Crossed eyes, Handwriting that gets worse, Difficulty at school, Difficulty understanding what people are saying, Hearing loss, Hyperactivity, Worsening nervous system damage, including coma, decreased fine motor control, and paralysis, Seizures, Swallowing difficulties, Visual impairment or blindness. […] The childhood form of X-linked ALD is a progressive disease. It leads to a long-term coma (vegetative state) about 2 years after nervous system symptoms develop. The child can live in this condition for as long as 10 years until death occurs. […] The other forms of this disease are milder.

• #17 Adrenoleukodystrophy | Baby’s First Test | Newborn Screening | Baby Health

  https://www.babysfirsttest.org/newborn-screening/conditions/adrenoleukodystrophy

  Adrenoleukodystrophy (ALD) occurs when certain fats (very long chain fatty acids, or VLCFAs) cannot be broken down in the body. These fats build up and affect how the body normally functions. This disease largely affects the nervous system and adrenal glands. When an individual has ALD, the buildup of VLCFAs may disrupt the fatty covering (myelin) of the nerve cells in the brain and spinal cord causing the myelin to breakdown, which reduces the ability of the nerves to relay information to the brain. Without myelin, the nervous system cannot function properly causing for example difficulties swallowing or weakness in the legs. However these symptoms vary depending on the type and age of onset and other factors which are not well understood. […] Symptoms can begin as early as age 2 but more commonly between ages 4-10 years old.

• #18 ALD: Adrenoleukodystrophy, Disease, X-Linked

  https://my.clevelandclinic.org/health/diseases/6030-adrenoleukodystrophy-ald

  As the disease progresses, symptoms include vision problems, hearing loss, trouble walking, weak and stiff limbs, convulsions and seizures, dementia, trouble eating, and vomiting. Eventually, children lose most of their neurological abilities. They lose sight, hearing and voluntary movements. As the disease progresses, children end up in a vegetative state. They often pass away within two to three years of the neurological symptoms starting. […] Symptoms of adrenal insufficiency include fatigue, weight loss, nausea and vomiting, digestive problems, feeling weak, headaches in the morning, hypotension, hypoglycemia, and hyperpigmented skin, when the skin darkens unrelated to sun exposure. […] Symptoms include spasticity (muscle stiffness), weakness or paralysis of the lower limbs, ataxia, neurological conditions affecting movement, numbness and pain, erectile dysfunction, bowel incontinence, bladder control problems, and premature baldness.

• #19 Adrenoleukodystrophy

  https://www.brainfacts.org/diseases-and-disorders/neurological-disorders-az/diseases-a-to-z-from-ninds/adrenoleukodystrophy

  X-linked Adrenoleukodystrophy (ALD) is one of a group of genetic disorders called the leukodystrophies that cause damage to the myelin sheath, an insulating membrane that surrounds nerve cells in the brain. The loss of myelin and the progressive dysfunction of the adrenal gland are the primary characteristics of X-ALD. While nearly all patients with X-ALD suffer from adrenal insufficiency, also known as Addison’s disease, the neurological symptoms can begin either in childhood or in adulthood. The childhood cerebral form is the most severe, with onset between ages 4 and 10. The most common symptoms are usually behavioral changes such as abnormal withdrawal or aggression, poor memory, and poor school performance. Other symptoms include visual loss, learning disabilities, seizures, poorly articulated speech, difficulty swallowing, deafness, disturbances of gait and coordination, fatigue, intermittent vomiting, increased skin pigmentation, and progressive dementia. The milder adult-onset form is also known as adrenomyeloneuropathy (AMN), which typically begins between ages 21 and 35. Symptoms may include progressive stiffness, weakness or paralysis of the lower limbs, and ataxia. Although adult-onset ALD progresses more slowly than the classic childhood form, it can also result in deterioration of brain function. […] Prognosis for patients with childhood cerebral X-ALD is generally poor due to progressive neurological deterioration unless bone marrow transplantation is performed early. Death usually occurs within 1 to 10 years after the onset of symptoms. Adult-onset AMN will progress over decades.

• #20 Cerebral Adrenoleukodystrophy – Child Neurology Foundation

  https://www.childneurologyfoundation.org/disorder/cerebral-adrenoleukodystrophy/

  Cerebral ALD is a progressive neurological disorder. Severe forms can eventually lead to: […] Cerebral ALD typically presents in early childhood. Boys start showing symptoms between 4 and 10 years of age. […] As the disease progresses, children end up in a vegetative state. They lose all neurological function. They often pass away within 1 to 5 years of symptom onset. […] If untreated or when diagnosis is delayed, cerebral ALD is rapidly progressive. In these cases, within 1 to 5 years of diagnosis, children with ALD: […] It is not possible to outgrow cerebral ALD. Cerebral ALD causes progressive degeneration of the nervous system. It can lead to death within 5 to 10 years of diagnosis unless stem-cell transplantation is performed early. […] Short term studies have shown that early stem-cell transplantation is important. Early transplantation can mean:

• #21 Adrenoleukodystrophy | Baby’s First Test | Newborn Screening | Baby Health

  https://www.babysfirsttest.org/newborn-screening/conditions/adrenoleukodystrophy

  Boys with childhood cerebral ALD (cALD) usually start showing symptoms when they are between 4 and 10 years old. Symptoms start with attention deficit disorder/hyperactivity and then progress to the symptoms listed under condition characteristics. The condition progresses very quickly, and the child usually passes away a few years after symptoms first appear, although some with intensive medical treatment may survive longer. […] Children with childhood cerebral ALD (cALD) will have ongoing neurological deterioration. Unless HCT (stem cell bone marrow transplantation) is done early, the child will continue to lose neurologic abilities. Sadly without HCT, most children with cALD will die before age ten. The best results from HCT are seen if the transplant is performed when the beginning changes to the brain are detected by MRI but before physical symptoms are seen. […] The other forms of ALD are milder, and will progress over decades. AMN may result in early death due to nervous system deterioration, but Addison disease can be managed through regular testing and treatment with replacement corticosteroid.

• #22 Adrenoleukodystrophy | Children’s Hospital of Philadelphia

  https://www.chop.edu/conditions-diseases/adrenoleukodystrophy

  As the disease progresses, symptoms include visual disturbances, loss of hearing, seizures, and trouble moving or speaking, eventually leading to loss of all body functions over a few years. […] Every child identified with ALD through the newborn screening must receive standardized neurologic monitoring throughout childhood that includes blood work and brain MRIs. This allows clinicians to see changes in the brain before the child shows any physical symptoms. This also allows treatment of adrenal insufficiency, which can be life threatening. If the care team sees anything concerning, they can provide personalized intervention immediately before a child has permanent injury to their brain. Targeted treatment of CALD has the best outcome when performed on an individual before symptoms are clinically visible. […] In recent clinical trials, gene therapy has shown promising results in stabilizing the progression of the disease in boys with early-stage CALD. However, additional research is necessary to assess its long-term effectiveness and safety.

• #23 Adrenoleukodystrophy – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK562328/

  Adrenomyeloneuropathy is a milder spectrum of X-ALD. The typical age at presentation is usually in the third decade of life for men and post-menopausal for women, with initial symptoms often involving spinal cord dysfunction. […] Most men who survive until adulthood have the adrenomyeloneuropathy form of adrenoleukodystrophy. This form is characterized by a chronic progressive axonopathy affecting the sensory and motor spinal cord tracts, leading to progressive spastic paraparesis, peripheral neuropathy, bowel and bladder sphincter dysfunction, and sexual dysfunction, sometimes accompanied by adrenal insufficiency. […] The prognosis for neonatal adrenoleukodystrophy and most forms of X-ALD is generally poor. However, patients with adrenomyeloneuropathy can survive past age 65, although often with significant morbidity.

• #24 Facts about ALD |

  https://adrenoleukodystrophy.info/clinical-diagnosis/facts-on-ald

  Adrenoleukodystrophy (ALD) is a genetic disorder that affects the adrenal glands, spinal cord, and the white matter of the brain. It is severe and progressive. […] The clinical course is different in males and females. […] In males, the first noticeable symptom of ALD is often adrenal insufficiency, which can occur in infancy. Cerebral ALD, which is progressive cerebral demyelination, can develop in childhood or adulthood. […] Boys and men with ALD may experience adrenal insufficiency and potentially life-threatening Addisonian crises as their first symptoms, which can occur years or even decades before neurological symptoms develop. […] Most male patients with ALD who reach adulthood will eventually develop myelopathy. This typically occurs between the ages of 20 and 40. Symptoms primarily affect the spinal cord and peripheral nerves.

• #25 Adrenoleukodystrophy – Symptoms and causes – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/adrenoleukodystrophy/symptoms-causes/syc-20369157

  Adrenoleukodystrophy (ALD) is a type of hereditary (genetic) condition that damages the membrane (myelin sheath) that insulates nerve cells in your brain. […] The white matter of the brain is progressively damaged (leukodystrophy), and symptoms worsen over time. If not diagnosed early, childhood-onset ALD may lead to death within five to 10 years. […] This adult-onset form of X-linked ALD is a less severe and slowly progressive form that causes symptoms such as a stiff gait and bladder and bowel dysfunction.

• #26 X-linked adrenoleukodystrophy: MedlinePlus GeneticsLock

  https://medlineplus.gov/genetics/condition/x-linked-adrenoleukodystrophy/

  Signs and symptoms of the adrenomyeloneuropathy type appear between early adulthood and middle age. Affected individuals develop progressive stiffness and weakness in their legs (paraparesis), experience urinary and genital tract disorders, and often show changes in behavior and intellectual function. Most people with the adrenomyeloneuropathy type also have adrenocortical insufficiency. Some severely affected individuals develop cerebral X-linked adrenoleukodystrophy. […] People with X-linked adrenoleukodystrophy whose only symptom is adrenocortical insufficiency are said to have the adrenal insufficiency only form. In these individuals, adrenocortical insufficiency can begin anytime between the first year of life and adulthood. However, most affected individuals develop the additional features of cerebral X-linked adrenoleukodystrophy in childhood or the adrenomyeloneuropathy type by the time they reach middle age. The life expectancy of individuals with the adrenal insufficiency form depends on the severity of the signs and symptoms, but typically this is the mildest of the three types.

• #27 X-Linked Adrenoleukodystrophy: Symptoms, Causes, and Treatment

  https://www.healthline.com/health/x-linked-adrenoleukodystrophy

  It causes symptoms like: progressive stiffness and weakness in your legs, walking problems, neuropathy, which causes numbness and pain in your limbs, erectile dysfunction, bladder and bowel control issues, premature balding. […] At least 20% of people with the adult form of X-ALD develop cognitive decline similar to that seen in the childhood form. It usually results in severe neurological impairment and, eventually, a vegetative state. […] About 10% of people with X-ALD only have symptoms of Addisons disease. […] Females who carry an associated gene mutation often develop symptoms in adulthood. Symptoms are usually less severe. About 20% of female gene carriers under 40 years old develop symptoms, but this increases to 90% by age 60 years. Addisons disease and brain involvement are rare in females.

• #28 ALD Phenotypes: Symptomatic Women | ALD Connect

  https://aldconnect.org/what-is-ald/symptomatic-women/

  Women with adrenoleukodystrophy (ALD) experience neurological symptoms such as progressive stiffness, weakness in the legs, and difficulty with mobility. Other symptoms may include pain, bladder and bowel dysfunction. […] Women with adrenoleukodystrophy (ALD) can experience symptoms that range from mild to severe and may include difficulty walking, muscle stiffness, pain, and bowel or bladder dysfunction—paralleling some of the challenges faced by men with adrenomyeloneuropathy (AMN). Symptoms may include some, all, or none of the following: Ataxia: loss of the ability to coordinate muscle movement, Falling or tripping, Fatigue and sleep disturbances, Hypertonia: excessive muscle tone, Peripheral neuropathy: pain, numbness, or tingling in the legs or feet, Sexual dysfunction, Spastic paraparesis: gradual, progressive weakness and stiffness of the legs, Urinary disturbances or incontinence and bowel urgency or incontinence, Walking and balance problems: general leg weakness and stiffness as well as decreased balance that can progress to difficulty walking or an unusual gait (mobility devices such as canes, walkers, and wheelchairs may be needed over time). […] While the neurological symptoms in women tend to progress more slowly, they can still significantly impact quality of life. Regular monitoring and symptom management are crucial for maintaining mobility and function.

• #29 Adrenoleukodystrophy (ALD): Causes, Types, Symptoms, Prognosis

  https://www.webmd.com/brain/what-is-adrenoleukodystrophy

  This adult form of ALD tends to have milder symptoms. About half of those who have it dont show signs until theyre in their 20s or 30s. Still, like ALD, AMN can cause a severe loss of brain function. Some early signs are: Trouble walking, Balance problems, Changes in your gait (how you walk), Numbness or tingling in the legs, Arm weakness, Feeling an urgent need to pee or poop, Incontinence, Not being able to get or keep an erection. […] Over time, ALD causes severe damage to the adrenal glands. This cant be reversed. The symptoms include: Weakness, Fatigue, Nausea, Low blood pressure, Darkened skin, Stomach pain. […] Women who inherit the mutated gene that causes ALD often dont have the brain disease, but they may show mild symptoms. Most of the time, these start after the age of 35. They can include: Weakness, Numbness, Joint pain, Urinary problems.

• #30 Adrenoleukodystrophy – United Leukodystrophy Foundation

  https://ulf.org/leukodystrophies/adrenoleukodystrophy/

  The symptoms are similar to those of childhood cerebral ALD, though progression of the disease may be somewhat slower. […] The first symptoms of AMN usually occur in the twenties. Generally, initial symptoms noted are stiffness/clumsiness in the legs, weight loss, attacks of nausea, and generalized weakness. Adrenal impairment occurs, and other major manifestations may include difficulty with walking, urinary disturbance and impotence, cognitive defects, emotional disturbances, and depression. The disease progresses slowly, and within 5 to 15 years the patient will generally need the aid of a cane or wheelchair. […] The symptoms are similar to those of schizophrenia with dementia, and the progression of the disorder is rapid. The average time from the initial symptoms to vegetative state or death is approximately 3-4 years.

• #31 Adrenoleukodystrophy

  https://www.brainfacts.org/diseases-and-disorders/neurological-disorders-az/diseases-a-to-z-from-ninds/adrenoleukodystrophy

  X-linked Adrenoleukodystrophy (ALD) is one of a group of genetic disorders called the leukodystrophies that cause damage to the myelin sheath, an insulating membrane that surrounds nerve cells in the brain. The loss of myelin and the progressive dysfunction of the adrenal gland are the primary characteristics of X-ALD. While nearly all patients with X-ALD suffer from adrenal insufficiency, also known as Addison’s disease, the neurological symptoms can begin either in childhood or in adulthood. The childhood cerebral form is the most severe, with onset between ages 4 and 10. The most common symptoms are usually behavioral changes such as abnormal withdrawal or aggression, poor memory, and poor school performance. Other symptoms include visual loss, learning disabilities, seizures, poorly articulated speech, difficulty swallowing, deafness, disturbances of gait and coordination, fatigue, intermittent vomiting, increased skin pigmentation, and progressive dementia. The milder adult-onset form is also known as adrenomyeloneuropathy (AMN), which typically begins between ages 21 and 35. Symptoms may include progressive stiffness, weakness or paralysis of the lower limbs, and ataxia. Although adult-onset ALD progresses more slowly than the classic childhood form, it can also result in deterioration of brain function. […] Prognosis for patients with childhood cerebral X-ALD is generally poor due to progressive neurological deterioration unless bone marrow transplantation is performed early. Death usually occurs within 1 to 10 years after the onset of symptoms. Adult-onset AMN will progress over decades.

• #32 X-Linked Adrenoleukodystrophy: Symptoms, Causes, and Treatment

  https://www.healthline.com/health/x-linked-adrenoleukodystrophy

  It causes symptoms like: progressive stiffness and weakness in your legs, walking problems, neuropathy, which causes numbness and pain in your limbs, erectile dysfunction, bladder and bowel control issues, premature balding. […] At least 20% of people with the adult form of X-ALD develop cognitive decline similar to that seen in the childhood form. It usually results in severe neurological impairment and, eventually, a vegetative state. […] About 10% of people with X-ALD only have symptoms of Addisons disease. […] Females who carry an associated gene mutation often develop symptoms in adulthood. Symptoms are usually less severe. About 20% of female gene carriers under 40 years old develop symptoms, but this increases to 90% by age 60 years. Addisons disease and brain involvement are rare in females.

• #33 Adrenoleukodystrophy – United Leukodystrophy Foundation

  https://ulf.org/leukodystrophies/adrenoleukodystrophy/

  The symptoms are similar to those of childhood cerebral ALD, though progression of the disease may be somewhat slower. […] The first symptoms of AMN usually occur in the twenties. Generally, initial symptoms noted are stiffness/clumsiness in the legs, weight loss, attacks of nausea, and generalized weakness. Adrenal impairment occurs, and other major manifestations may include difficulty with walking, urinary disturbance and impotence, cognitive defects, emotional disturbances, and depression. The disease progresses slowly, and within 5 to 15 years the patient will generally need the aid of a cane or wheelchair. […] The symptoms are similar to those of schizophrenia with dementia, and the progression of the disorder is rapid. The average time from the initial symptoms to vegetative state or death is approximately 3-4 years.

• #34 X-Linked Adrenoleukodystrophy – GeneReviews® – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK1315/

  While variable, the rate of disease progression may be rapid, with total disability occurring within six months to two years, followed by death at varying ages. […] The typical presentation is a man in his adult years who develops progressive stiffness and weakness in the legs (due to spastic paraparesis), abnormalities of bladder and bowel control, abnormal sensory perception (especially of vibratory sense), and sexual dysfunction. All manifestations progress over decades. […] Approximately 40%-45% of individuals with AMN show some degree of involvement on brain MRI or clinical examination. In 20%-63% of individuals with AMN, progressive brain involvement leads to serious cognitive and behavioral disturbances that may progress to total disability and death. […] Males can present with signs of adrenal insufficiency at any age, although commonly by age 7.5 years. Presenting signs include unexplained vomiting and weakness or coma, leading to the diagnosis of primary adrenocortical insufficiency. A variable finding is increased skin pigmentation resulting from excessive adrenocorticotropic hormone secretion. Overall, adrenocortical function is abnormal in 90% of neurologically symptomatic boys and 70% of men with AMN. Most males who are initially diagnosed as having only primary adrenocortical insufficiency will develop some neurologic manifestations; however, it may be decades later.

• #35 Adrenoleukodystrophy – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK562328/

  Adrenomyeloneuropathy is a milder spectrum of X-ALD. The typical age at presentation is usually in the third decade of life for men and post-menopausal for women, with initial symptoms often involving spinal cord dysfunction. […] Most men who survive until adulthood have the adrenomyeloneuropathy form of adrenoleukodystrophy. This form is characterized by a chronic progressive axonopathy affecting the sensory and motor spinal cord tracts, leading to progressive spastic paraparesis, peripheral neuropathy, bowel and bladder sphincter dysfunction, and sexual dysfunction, sometimes accompanied by adrenal insufficiency. […] The prognosis for neonatal adrenoleukodystrophy and most forms of X-ALD is generally poor. However, patients with adrenomyeloneuropathy can survive past age 65, although often with significant morbidity.

• #36 Adrenoleukodystrophy – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK562328/

  Typical signs and symptoms of neonatal adrenoleukodystrophy include seizures, hypotonia, and hearing dysfunction, vision loss, cataracts, and optic nerve dysplasia, jaundice and hepatomegaly, failure to thrive and facial dysmorphism. […] Childhood cerebral adrenoleukodystrophy typically presents between ages 3 and 10. The hallmark of this form is developmental regression, and it is characterized by progressive sensory and severe neurological deficits, which often lead to significant disability, coma, and eventually death. […] Addison disease is characterized by adrenal gland dysfunction in X-ALD. This phenotype results from reduced production of aldosterone and cortisol, leading to manifestations such as hyponatremia, fatigue, hypotension, dehydration, hypoglycemia, and generalized weakness.

• #37 Managing Adrenal Insufficiency Symptoms

  https://www.navigatingald.com/living-with-ald/adrenal-insufficiency-symptoms

  If adrenal insufficiency leads to a diagnosis of adrenoleukodystrophy (ALD), it is important to see an endocrinologist who can help you manage the adrenal symptoms of the disease. Regular visits to your endocrinologist will allow them to help monitor, assess, and manage adrenal symptoms such as fatigue, loss of appetite, hyperpigmentation (skin darkening) and belly pain. […] Managing the adrenal aspects of ALD is an important part of your childs care because adrenal insufficiency can lead to adrenal crisis if left unchecked. Adrenal crisis refers to a life-threatening condition that occurs when there is not enough cortisol, a hormone produced by the adrenal gland. […] Symptoms and signs of adrenal crisis can include: abdominal pain, confusion, loss of consciousness, or coma, fatigue, severe weakness, hypotension (very low blood pressure), dehydration, high fever.

• #38 Adrenoleukodystrophy (ALD): Causes, Types, Symptoms, Prognosis

  https://www.webmd.com/brain/what-is-adrenoleukodystrophy

  This adult form of ALD tends to have milder symptoms. About half of those who have it dont show signs until theyre in their 20s or 30s. Still, like ALD, AMN can cause a severe loss of brain function. Some early signs are: Trouble walking, Balance problems, Changes in your gait (how you walk), Numbness or tingling in the legs, Arm weakness, Feeling an urgent need to pee or poop, Incontinence, Not being able to get or keep an erection. […] Over time, ALD causes severe damage to the adrenal glands. This cant be reversed. The symptoms include: Weakness, Fatigue, Nausea, Low blood pressure, Darkened skin, Stomach pain. […] Women who inherit the mutated gene that causes ALD often dont have the brain disease, but they may show mild symptoms. Most of the time, these start after the age of 35. They can include: Weakness, Numbness, Joint pain, Urinary problems.

• #39 ALD: Adrenoleukodystrophy, Disease, X-Linked

  https://my.clevelandclinic.org/health/diseases/6030-adrenoleukodystrophy-ald

  As the disease progresses, symptoms include vision problems, hearing loss, trouble walking, weak and stiff limbs, convulsions and seizures, dementia, trouble eating, and vomiting. Eventually, children lose most of their neurological abilities. They lose sight, hearing and voluntary movements. As the disease progresses, children end up in a vegetative state. They often pass away within two to three years of the neurological symptoms starting. […] Symptoms of adrenal insufficiency include fatigue, weight loss, nausea and vomiting, digestive problems, feeling weak, headaches in the morning, hypotension, hypoglycemia, and hyperpigmented skin, when the skin darkens unrelated to sun exposure. […] Symptoms include spasticity (muscle stiffness), weakness or paralysis of the lower limbs, ataxia, neurological conditions affecting movement, numbness and pain, erectile dysfunction, bowel incontinence, bladder control problems, and premature baldness.

• #40 Adrenoleukodystrophy: MedlinePlus Medical EncyclopediaLock

  https://medlineplus.gov/ency/article/001182.htm

  Adrenoleukodystrophy (ALD) describes several closely related disorders that disrupt the breakdown of certain fats. These disorders are often passed down (inherited) in families. […] Childhood cerebral type symptoms include: Changes in muscle tone, especially muscle spasms and uncontrolled movements, Crossed eyes, Handwriting that gets worse, Difficulty at school, Difficulty understanding what people are saying, Hearing loss, Hyperactivity, Worsening nervous system damage, including coma, decreased fine motor control, and paralysis, Seizures, Swallowing difficulties, Visual impairment or blindness. […] Adrenomyelopathy symptoms include: Difficulty controlling urination, Possible worsening muscle weakness or leg stiffness, Problems with thinking speed and visual memory. […] Adrenal gland failure (Addison type) symptoms include: Coma, Decreased appetite, Increased skin color, Loss of weight and muscle mass (wasting), Muscle weakness, Vomiting. […] The childhood form of X-linked ALD is a progressive disease. It leads to a long-term coma (vegetative state) about 2 years after nervous system symptoms develop. The child can live in this condition for as long as 10 years until death occurs. […] The other forms of this disease are milder.

• #41 Adrenoleukodystrophy – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK562328/

  Typical signs and symptoms of neonatal adrenoleukodystrophy include seizures, hypotonia, and hearing dysfunction, vision loss, cataracts, and optic nerve dysplasia, jaundice and hepatomegaly, failure to thrive and facial dysmorphism. […] Childhood cerebral adrenoleukodystrophy typically presents between ages 3 and 10. The hallmark of this form is developmental regression, and it is characterized by progressive sensory and severe neurological deficits, which often lead to significant disability, coma, and eventually death. […] Addison disease is characterized by adrenal gland dysfunction in X-ALD. This phenotype results from reduced production of aldosterone and cortisol, leading to manifestations such as hyponatremia, fatigue, hypotension, dehydration, hypoglycemia, and generalized weakness.

• #42 Managing Adrenal Insufficiency Symptoms

  https://www.navigatingald.com/living-with-ald/adrenal-insufficiency-symptoms

  If adrenal insufficiency leads to a diagnosis of adrenoleukodystrophy (ALD), it is important to see an endocrinologist who can help you manage the adrenal symptoms of the disease. Regular visits to your endocrinologist will allow them to help monitor, assess, and manage adrenal symptoms such as fatigue, loss of appetite, hyperpigmentation (skin darkening) and belly pain. […] Managing the adrenal aspects of ALD is an important part of your childs care because adrenal insufficiency can lead to adrenal crisis if left unchecked. Adrenal crisis refers to a life-threatening condition that occurs when there is not enough cortisol, a hormone produced by the adrenal gland. […] Symptoms and signs of adrenal crisis can include: abdominal pain, confusion, loss of consciousness, or coma, fatigue, severe weakness, hypotension (very low blood pressure), dehydration, high fever.

• #43 Adrenoleukodystrophy: MedlinePlus Medical EncyclopediaLock

  https://medlineplus.gov/ency/article/001182.htm

  Adrenoleukodystrophy (ALD) describes several closely related disorders that disrupt the breakdown of certain fats. These disorders are often passed down (inherited) in families. […] Childhood cerebral type symptoms include: Changes in muscle tone, especially muscle spasms and uncontrolled movements, Crossed eyes, Handwriting that gets worse, Difficulty at school, Difficulty understanding what people are saying, Hearing loss, Hyperactivity, Worsening nervous system damage, including coma, decreased fine motor control, and paralysis, Seizures, Swallowing difficulties, Visual impairment or blindness. […] Adrenomyelopathy symptoms include: Difficulty controlling urination, Possible worsening muscle weakness or leg stiffness, Problems with thinking speed and visual memory. […] Adrenal gland failure (Addison type) symptoms include: Coma, Decreased appetite, Increased skin color, Loss of weight and muscle mass (wasting), Muscle weakness, Vomiting. […] The childhood form of X-linked ALD is a progressive disease. It leads to a long-term coma (vegetative state) about 2 years after nervous system symptoms develop. The child can live in this condition for as long as 10 years until death occurs. […] The other forms of this disease are milder.

• #44 Adrenoleukodystrophy / Adrenomyeloneuropathy – National Adrenal Diseases Foundation

  https://www.nadf.us/adrenoleukodystrophy-adrenomyeloneuropathy.html

  The age of onset for adrenomyeloneuropathy is typically early adulthood, but can be later. Symptoms include leg stiffness and weakness, genitourinary tract disorders, and behavior changes. Addisons disease is common in AMN. […] The ADDISONS DISEASE ONLY form presents anytime from early childhood through adult life with non-specific symptoms and signs of weakness, weight loss and failure to thrive, skin darkening, vomiting, and shock. Lifelong replacement hormones (usually oral glucocorticoids and mineralocorticoids) are required in such cases, and will usually prevent episodes of acute adrenal insufficiency. […] Life expectancy depends on the severity of the signs and symptoms, timing of the diagnosis and treatment for adrenal insufficiency.

• #45 Managing Adrenal Insufficiency Symptoms

  https://www.navigatingald.com/living-with-ald/adrenal-insufficiency-symptoms

  Adrenal crisis can occur more frequently after an infection, trauma, or another stressor. It can lead to severe effects and require emergency medical treatment. […] If your child has been diagnosed with adrenal insufficiency, its important to recognize signs of potential stress that can lead to an adrenal crisis. Your care team, including your endocrinologist, can work with you to recognize and manage adrenal symptoms.

• #46 Women with ALD |

  https://adrenoleukodystrophy.info/clinical-diagnosis/females-with-ald

  It has been known since the 1980s that women with ALD can develop symptoms. […] In a study conducted at the AMC in the Netherlands, it was shown the frequency of symptomatic women with ALD increases with age. More than 80% of women with ALD will develop signs of neurological dysfunction by the age of 60. […] Symptoms in affected women are mainly due to abnormalities in the spinal cord and nerves in the legs, just as in men with the spinal cord form (myelopathy). Over decades, weakness and spasticity of the legs, loss of sensation in the lower limbs, and impaired bladder and bowel control develop. […] Unlike men, women are very unlikely to develop adrenal insufficiency, although it has been described in 1% of a large group. […] Many women with ALD who have mild symptoms remain undiagnosed for many years. As a result, specific treatment for spasticity, lower back or joint pain, and bladder and bowel dysfunction may be withheld. […] Many, if not most, women with ALD will develop neurological symptoms caused by damage to the spinal cord and peripheral nerves. It is important to recognize these symptoms for effective symptomatic treatment.

• #47 Facts about ALD |

  https://adrenoleukodystrophy.info/clinical-diagnosis/facts-on-ald

  Boys and men with ALD may develop demyelinating lesions in the white matter of the brain, known as cerebral ALD. […] Symptoms of cerebral ALD typically progress rapidly. Males born with the disease have a 35 to 40% chance of developing cerebral ALD between the ages of 3 and 18. […] It is now well established that more than 80% of women who carry the defective ALD gene will develop symptoms by the age of 60, contrary to the initial assumption that they will remain asymptomatic. […] Neurological symptoms in women typically begin at a later age (between 40 and 50 years) than in men with myelopathy. Disease progression is generally slower than in males.

• #48 Minoryx adrenoleukodystrophy orphan diseases

  https://www.minoryx.com/adrenoleukodystrophy-orphan-disease/

  Female AMN is increasingly recognized as a relevant form, because up to 80% of heterozygous females (with one of the two X-chromosomes affected) will develop AMN symptoms with onset typically, between 40 to 50 years of age. The symptoms are similar to males with AMN, but usually, women do not develop cerebral involvement.

• #49 Women with Adrenoleukodystrophy – Adrenoleukodystrophy News

  https://adrenoleukodystrophynews.com/women-with-adrenoleukodystrophy/

  When present, commonly observed symptoms include chronic leg muscle weakness affecting gait, spasticity, or muscle stiffness, and bowel and bladder dysfunction. […] A study published in the scientific journal Brain found that, in 46 female ALD carriers older than 18, peripheral neuropathy — tingling and numbness in the hands and feet — and spinal cord disease, or myelopathy, were the two leading symptoms. Poor bowel and bladder control were also reported. Other symptoms included abnormal muscle reflexes and gait disorders. […] Similarly, a study published in the journal Case Reports in Neurological Medicine described the case of a 35-year-old woman who was identified as an ALD carrier as part of a family genetic screening when her brother was diagnosed with the condition. Although family history helped in her diagnosis, her initial symptoms were mild. She reported balance issues, knee pain, heaviness in her hands and feet, and problems in normal activities such as running, jumping, or climbing stairs.

• #50 ALD Phenotypes: Symptomatic Women | ALD Connect

  https://aldconnect.org/what-is-ald/symptomatic-women/

  Women with adrenoleukodystrophy (ALD) experience neurological symptoms such as progressive stiffness, weakness in the legs, and difficulty with mobility. Other symptoms may include pain, bladder and bowel dysfunction. […] Women with adrenoleukodystrophy (ALD) can experience symptoms that range from mild to severe and may include difficulty walking, muscle stiffness, pain, and bowel or bladder dysfunction—paralleling some of the challenges faced by men with adrenomyeloneuropathy (AMN). Symptoms may include some, all, or none of the following: Ataxia: loss of the ability to coordinate muscle movement, Falling or tripping, Fatigue and sleep disturbances, Hypertonia: excessive muscle tone, Peripheral neuropathy: pain, numbness, or tingling in the legs or feet, Sexual dysfunction, Spastic paraparesis: gradual, progressive weakness and stiffness of the legs, Urinary disturbances or incontinence and bowel urgency or incontinence, Walking and balance problems: general leg weakness and stiffness as well as decreased balance that can progress to difficulty walking or an unusual gait (mobility devices such as canes, walkers, and wheelchairs may be needed over time). […] While the neurological symptoms in women tend to progress more slowly, they can still significantly impact quality of life. Regular monitoring and symptom management are crucial for maintaining mobility and function.

• #51 Women with Adrenoleukodystrophy – Adrenoleukodystrophy News

  https://adrenoleukodystrophynews.com/women-with-adrenoleukodystrophy/

  When present, commonly observed symptoms include chronic leg muscle weakness affecting gait, spasticity, or muscle stiffness, and bowel and bladder dysfunction. […] A study published in the scientific journal Brain found that, in 46 female ALD carriers older than 18, peripheral neuropathy — tingling and numbness in the hands and feet — and spinal cord disease, or myelopathy, were the two leading symptoms. Poor bowel and bladder control were also reported. Other symptoms included abnormal muscle reflexes and gait disorders. […] Similarly, a study published in the journal Case Reports in Neurological Medicine described the case of a 35-year-old woman who was identified as an ALD carrier as part of a family genetic screening when her brother was diagnosed with the condition. Although family history helped in her diagnosis, her initial symptoms were mild. She reported balance issues, knee pain, heaviness in her hands and feet, and problems in normal activities such as running, jumping, or climbing stairs.

• #52 ALD Phenotypes: Symptomatic Women | ALD Connect

  https://aldconnect.org/what-is-ald/symptomatic-women/

  Women with adrenoleukodystrophy (ALD) experience neurological symptoms such as progressive stiffness, weakness in the legs, and difficulty with mobility. Other symptoms may include pain, bladder and bowel dysfunction. […] Women with adrenoleukodystrophy (ALD) can experience symptoms that range from mild to severe and may include difficulty walking, muscle stiffness, pain, and bowel or bladder dysfunction—paralleling some of the challenges faced by men with adrenomyeloneuropathy (AMN). Symptoms may include some, all, or none of the following: Ataxia: loss of the ability to coordinate muscle movement, Falling or tripping, Fatigue and sleep disturbances, Hypertonia: excessive muscle tone, Peripheral neuropathy: pain, numbness, or tingling in the legs or feet, Sexual dysfunction, Spastic paraparesis: gradual, progressive weakness and stiffness of the legs, Urinary disturbances or incontinence and bowel urgency or incontinence, Walking and balance problems: general leg weakness and stiffness as well as decreased balance that can progress to difficulty walking or an unusual gait (mobility devices such as canes, walkers, and wheelchairs may be needed over time). […] While the neurological symptoms in women tend to progress more slowly, they can still significantly impact quality of life. Regular monitoring and symptom management are crucial for maintaining mobility and function.

• #53 What is ALD? — The Stop ALD Foundation

  http://www.stopald.org/what-is-ald

  Although women who carry the ALD gene mutation do not generally develop the brain disease itself, some display mild symptoms of the disorder. These symptoms usually develop after age 35, and primarily include progressive stiffness, weakness, or paralysis of the lower limbs, numbness, pain in the joints, and urinary problems.

• #54 ALD Phenotypes: Symptomatic Women | ALD Connect

  https://aldconnect.org/what-is-ald/symptomatic-women/

  Women with adrenoleukodystrophy (ALD) experience neurological symptoms such as progressive stiffness, weakness in the legs, and difficulty with mobility. Other symptoms may include pain, bladder and bowel dysfunction. […] Women with adrenoleukodystrophy (ALD) can experience symptoms that range from mild to severe and may include difficulty walking, muscle stiffness, pain, and bowel or bladder dysfunction—paralleling some of the challenges faced by men with adrenomyeloneuropathy (AMN). Symptoms may include some, all, or none of the following: Ataxia: loss of the ability to coordinate muscle movement, Falling or tripping, Fatigue and sleep disturbances, Hypertonia: excessive muscle tone, Peripheral neuropathy: pain, numbness, or tingling in the legs or feet, Sexual dysfunction, Spastic paraparesis: gradual, progressive weakness and stiffness of the legs, Urinary disturbances or incontinence and bowel urgency or incontinence, Walking and balance problems: general leg weakness and stiffness as well as decreased balance that can progress to difficulty walking or an unusual gait (mobility devices such as canes, walkers, and wheelchairs may be needed over time). […] While the neurological symptoms in women tend to progress more slowly, they can still significantly impact quality of life. Regular monitoring and symptom management are crucial for maintaining mobility and function.

• #55 Women with ALD |

  https://adrenoleukodystrophy.info/clinical-diagnosis/females-with-ald

  It has been known since the 1980s that women with ALD can develop symptoms. […] In a study conducted at the AMC in the Netherlands, it was shown the frequency of symptomatic women with ALD increases with age. More than 80% of women with ALD will develop signs of neurological dysfunction by the age of 60. […] Symptoms in affected women are mainly due to abnormalities in the spinal cord and nerves in the legs, just as in men with the spinal cord form (myelopathy). Over decades, weakness and spasticity of the legs, loss of sensation in the lower limbs, and impaired bladder and bowel control develop. […] Unlike men, women are very unlikely to develop adrenal insufficiency, although it has been described in 1% of a large group. […] Many women with ALD who have mild symptoms remain undiagnosed for many years. As a result, specific treatment for spasticity, lower back or joint pain, and bladder and bowel dysfunction may be withheld. […] Many, if not most, women with ALD will develop neurological symptoms caused by damage to the spinal cord and peripheral nerves. It is important to recognize these symptoms for effective symptomatic treatment.

• #56 Orphanet: X-linked adrenoleukodystrophy

  https://www.orpha.net/en/disease/detail/43

  About 90% develop a myelopathy and peripheral neuropathy, but at a later age (after 40 years of age) and with slower progression (over decades) than in males. […] There is currently no treatment to prevent the occurrence or progression of the myelopathy. However, with appropriate supportive care life expectancy is near normal.

• #57 The First Signs of Adrenoleukodystrophy and When They Appear

  https://adrenoleukodystrophynews.com/2020/05/11/first-signs-adrenoleukodystrophy-and-when-they-appear/

  Adult-onset cerebral ALD is rare, but tends to progress rapidly once neurological symptoms appear. These symptoms can be similar to schizophrenia with dementia. […] As AMN progresses, patients develop adrenal impairment when the adrenal glands don’t make enough of certain hormones. Within five to 15 years of diagnosis, patients may need a cane or a wheelchair.

• #58 Adrenoleukodystrophy – United Leukodystrophy Foundation

  https://ulf.org/leukodystrophies/adrenoleukodystrophy/

  The symptoms are similar to those of childhood cerebral ALD, though progression of the disease may be somewhat slower. […] The first symptoms of AMN usually occur in the twenties. Generally, initial symptoms noted are stiffness/clumsiness in the legs, weight loss, attacks of nausea, and generalized weakness. Adrenal impairment occurs, and other major manifestations may include difficulty with walking, urinary disturbance and impotence, cognitive defects, emotional disturbances, and depression. The disease progresses slowly, and within 5 to 15 years the patient will generally need the aid of a cane or wheelchair. […] The symptoms are similar to those of schizophrenia with dementia, and the progression of the disorder is rapid. The average time from the initial symptoms to vegetative state or death is approximately 3-4 years.

• #59 Adrenoleukodystrophy – United Leukodystrophy Foundation

  https://ulf.org/leukodystrophies/adrenoleukodystrophy/

  The symptoms are similar to those of childhood cerebral ALD, though progression of the disease may be somewhat slower. […] The first symptoms of AMN usually occur in the twenties. Generally, initial symptoms noted are stiffness/clumsiness in the legs, weight loss, attacks of nausea, and generalized weakness. Adrenal impairment occurs, and other major manifestations may include difficulty with walking, urinary disturbance and impotence, cognitive defects, emotional disturbances, and depression. The disease progresses slowly, and within 5 to 15 years the patient will generally need the aid of a cane or wheelchair. […] The symptoms are similar to those of schizophrenia with dementia, and the progression of the disorder is rapid. The average time from the initial symptoms to vegetative state or death is approximately 3-4 years.

• #60 Adrenoleukodystrophy – United Leukodystrophy Foundation

  https://ulf.org/leukodystrophies/adrenoleukodystrophy/

  The symptoms are similar to those of childhood cerebral ALD, though progression of the disease may be somewhat slower. […] The first symptoms of AMN usually occur in the twenties. Generally, initial symptoms noted are stiffness/clumsiness in the legs, weight loss, attacks of nausea, and generalized weakness. Adrenal impairment occurs, and other major manifestations may include difficulty with walking, urinary disturbance and impotence, cognitive defects, emotional disturbances, and depression. The disease progresses slowly, and within 5 to 15 years the patient will generally need the aid of a cane or wheelchair. […] The symptoms are similar to those of schizophrenia with dementia, and the progression of the disorder is rapid. The average time from the initial symptoms to vegetative state or death is approximately 3-4 years.

• #61 Adrenoleukodystrophy – United Leukodystrophy Foundation

  https://ulf.org/leukodystrophies/adrenoleukodystrophy/

  The symptoms are similar to those of childhood cerebral ALD, though progression of the disease may be somewhat slower. […] The first symptoms of AMN usually occur in the twenties. Generally, initial symptoms noted are stiffness/clumsiness in the legs, weight loss, attacks of nausea, and generalized weakness. Adrenal impairment occurs, and other major manifestations may include difficulty with walking, urinary disturbance and impotence, cognitive defects, emotional disturbances, and depression. The disease progresses slowly, and within 5 to 15 years the patient will generally need the aid of a cane or wheelchair. […] The symptoms are similar to those of schizophrenia with dementia, and the progression of the disorder is rapid. The average time from the initial symptoms to vegetative state or death is approximately 3-4 years.

• #62 X-Linked Adrenoleukodystrophy – GeneReviews® – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK1315/

  While variable, the rate of disease progression may be rapid, with total disability occurring within six months to two years, followed by death at varying ages. […] The typical presentation is a man in his adult years who develops progressive stiffness and weakness in the legs (due to spastic paraparesis), abnormalities of bladder and bowel control, abnormal sensory perception (especially of vibratory sense), and sexual dysfunction. All manifestations progress over decades. […] Approximately 40%-45% of individuals with AMN show some degree of involvement on brain MRI or clinical examination. In 20%-63% of individuals with AMN, progressive brain involvement leads to serious cognitive and behavioral disturbances that may progress to total disability and death. […] Males can present with signs of adrenal insufficiency at any age, although commonly by age 7.5 years. Presenting signs include unexplained vomiting and weakness or coma, leading to the diagnosis of primary adrenocortical insufficiency. A variable finding is increased skin pigmentation resulting from excessive adrenocorticotropic hormone secretion. Overall, adrenocortical function is abnormal in 90% of neurologically symptomatic boys and 70% of men with AMN. Most males who are initially diagnosed as having only primary adrenocortical insufficiency will develop some neurologic manifestations; however, it may be decades later.

• #63 Patient-reported impact of symptoms in adrenoleukodystrophy (PRISM-ALD) | Orphanet Journal of Rare Diseases | Full Text

  https://ojrd.biomedcentral.com/articles/10.1186/s13023-024-03129-6

  Adrenoleukodystrophy (ALD) is a multifaceted, X-linked, neurodegenerative disorder that comprises several clinical phenotypes. ALD affects patients through a variety of physical, emotional, social, and other disease-specific factors that collectively contribute to disease burden. […] The symptomatic themes with the highest prevalence in the overall ALD sample cohort were problems with balance (90.9%), limitations with mobility or walking (87.3%), fatigue (86.4%), and leg weakness (86.4%). The symptomatic themes with the highest impact scores (on a 04 scale with 4 being the most severe) were trouble getting around (2.35), leg weakness (2.25), and problems with balance (2.21). A higher prevalence of symptomatic themes was associated with functional disability, employment disruption, and speech impairment.

• #64 Patient-reported impact of symptoms in adrenoleukodystrophy (PRISM-ALD) | Orphanet Journal of Rare Diseases | Full Text

  https://ojrd.biomedcentral.com/articles/10.1186/s13023-024-03129-6

  Adrenoleukodystrophy (ALD) is a multifaceted, X-linked, neurodegenerative disorder that comprises several clinical phenotypes. ALD affects patients through a variety of physical, emotional, social, and other disease-specific factors that collectively contribute to disease burden. […] The symptomatic themes with the highest prevalence in the overall ALD sample cohort were problems with balance (90.9%), limitations with mobility or walking (87.3%), fatigue (86.4%), and leg weakness (86.4%). The symptomatic themes with the highest impact scores (on a 04 scale with 4 being the most severe) were trouble getting around (2.35), leg weakness (2.25), and problems with balance (2.21). A higher prevalence of symptomatic themes was associated with functional disability, employment disruption, and speech impairment.

• #65 Patient-reported impact of symptoms in adrenoleukodystrophy (PRISM-ALD) | Orphanet Journal of Rare Diseases | Full Text

  https://ojrd.biomedcentral.com/articles/10.1186/s13023-024-03129-6

  Clinical manifestations of ALD depend on the specific phenotype associated with the condition. The most common symptoms of AMN include weakness and spasticity in the legs, abnormal sphincter control, neurogenic bladder, sexual dysfunction, numbness, and pain. Cerebral ALD may show up as learning disabilities, behavioral abnormalities, cognitive decline, impaired vision and/or auditory discrimination, and seizures. Addisons disease may cause symptoms such as fatigue, muscle weakness, low mood/mild depression, nonspecific gastrointestinal issues, vomiting, weakness, and headaches. […] The symptomatic themes with the highest average impact scores (on a scale of 04) from the cross-sectional survey were trouble getting around (2.34), leg weakness (2.24), problems with balance (2.21), inability to do activities (2.12), and limitations with mobility or walking (2.12). The most impactful individual symptoms were difficulty playing sports (3.06), difficulty running (2.94), difficulty riding a bike (2.89), and difficulty dancing (2.82).

• #66 Patient-reported impact of symptoms in adrenoleukodystrophy (PRISM-ALD) | Orphanet Journal of Rare Diseases | Full Text

  https://ojrd.biomedcentral.com/articles/10.1186/s13023-024-03129-6

  Individuals who reported having anywhere from a slight to severe disability, compared to no symptoms or no significant disability, showed higher prevalence of 14 symptomatic themes; the most significant differences were in limitations with mobility or walking (99% vs. 57%), inability to do activities (99% vs. 40%), trouble getting around (95% vs. 23%), leg weakness (96% vs. 60%), decreased satisfaction in social situations (85% vs. 43%), and abnormal movements (65% vs. 20%). […] In ALD, the symptomatic themes with the highest prevalence were also those with the highest relative impact: problems with balance, limitations with mobility or walking, and leg weakness.

• #67 Adrenoleukodystrophy – Overview of Information and Clinical Research

  https://clinicaltrials.eu/disease/adrenoleukodystrophy/

  The childhood form of X-linked ALD is particularly aggressive. It often leads to a vegetative state within two years of the onset of neurological symptoms. […] Adult-onset ALD, also known as adrenomyeloneuropathy (AMN), is less severe than CALD. Symptoms such as a stiff gait and bladder and bowel dysfunction develop more slowly. While the progression is milder, the disease can still significantly impact lifespan and quality of life. […] Early diagnosis of ALD is crucial, as it allows for timely intervention that can slow disease progression and improve outcomes. Treatments are most effective when administered before significant neurological damage occurs.

• #68 The First Signs of Adrenoleukodystrophy and When They Appear

  https://adrenoleukodystrophynews.com/2020/05/11/first-signs-adrenoleukodystrophy-and-when-they-appear/

  Some states in the U.S. test newborns for adrenoleukodystrophy (ALD). This often is the first indication to parents that their child may have ALD. However, there are different types of ALD depending on which parts of the body the disease affects. These different types have very different ages of onset. […] If ALD affects the brain doctors call it cerebral ALD. They further divide cerebral ALD into subtypes based on the age of patients when symptoms appear: childhood, adolescence, and adult-onset cerebral ALD. […] The first signs of cerebral ALD may appear as early as age 2 (childhood-onset) although some patients don’t show symptoms until they are adults or middle-age. Most patients develop normally until initial symptoms appear. […] In children, cerebral ALD progresses rapidly. As the disease advances, patients develop dementia, poor coordination, seizures, hyperactivity, problems with speech, and headaches. Among those whose symptoms first appear in adolescence, disease progression usually is slower.

• #69 ALD Diagnosis | Tests, Screening and Symptoms

  https://www.navigatingald.com/what-is-ald/ald-diagnosis

  Since newborn screening for ALD isnt available in every state, many boys with ALD may be diagnosed through the onset of symptoms. In ALD, adrenal insufficiency is often the first detected symptom. Adrenal insufficiency is a condition where the adrenal glands arent producing enough of the hormones that are needed to regulate and balance the body. Adrenal insufficiency symptoms may include: fatigue, loss of appetite, hyperpigmentation (skin darkening), belly pain. […] These symptoms may also mimic other diseases, such as Addisons disease, so they can often be misdiagnosed as the symptoms can be unrelated to ALD. […] Neurologic symptoms of ALD can be difficult to differentiate from other conditions, such as ADHD, autism and other learning disabilities. Without additional testing to confirm ALD, symptoms can easily be mistaken for behavioral or developmental issues, and many boys can go misdiagnosed.

• #70 X-linked Adrenoleukodystrophy (ALD) | Division of Medical Genetics | Stanford Medicine

  https://med.stanford.edu/medicalgenetics/Metabolicdisease/ALD.html

  X-linked Adrenoleukodystrophy is a genetic condition that may be found on Newborn Screening, or can be diagnosed based on a variety of symptoms. Symptoms range in severity and age of onset. There are three main ways that the disease will present: […] Cerebral ALD- marked by progressive neurologic symptoms. […] Boys with ALD have normal development. Serious ALD complications (e.g. neurologic disability or death) generally occur only when we are not looking for them. Expert ALD clinicians have designed MRI and lab surveillance schedules to detect ALD complications before they cause permanent disability.

• #71 Adrenoleukodystrophy | Children’s Hospital of Philadelphia

  https://www.chop.edu/conditions-diseases/adrenoleukodystrophy

  As the disease progresses, symptoms include visual disturbances, loss of hearing, seizures, and trouble moving or speaking, eventually leading to loss of all body functions over a few years. […] Every child identified with ALD through the newborn screening must receive standardized neurologic monitoring throughout childhood that includes blood work and brain MRIs. This allows clinicians to see changes in the brain before the child shows any physical symptoms. This also allows treatment of adrenal insufficiency, which can be life threatening. If the care team sees anything concerning, they can provide personalized intervention immediately before a child has permanent injury to their brain. Targeted treatment of CALD has the best outcome when performed on an individual before symptoms are clinically visible. […] In recent clinical trials, gene therapy has shown promising results in stabilizing the progression of the disease in boys with early-stage CALD. However, additional research is necessary to assess its long-term effectiveness and safety.

• #72 Adrenoleukodystrophy | Children’s Hospital of Philadelphia

  https://www.chop.edu/conditions-diseases/adrenoleukodystrophy

  As the disease progresses, symptoms include visual disturbances, loss of hearing, seizures, and trouble moving or speaking, eventually leading to loss of all body functions over a few years. […] Every child identified with ALD through the newborn screening must receive standardized neurologic monitoring throughout childhood that includes blood work and brain MRIs. This allows clinicians to see changes in the brain before the child shows any physical symptoms. This also allows treatment of adrenal insufficiency, which can be life threatening. If the care team sees anything concerning, they can provide personalized intervention immediately before a child has permanent injury to their brain. Targeted treatment of CALD has the best outcome when performed on an individual before symptoms are clinically visible. […] In recent clinical trials, gene therapy has shown promising results in stabilizing the progression of the disease in boys with early-stage CALD. However, additional research is necessary to assess its long-term effectiveness and safety.

• #73 Adrenoleukodystrophy – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/adrenoleukodystrophy/diagnosis-treatment/drc-20369160

  To diagnose ALD, your doctor will review your symptoms and your medical and family history. […] Adrenoleukodystrophy has no cure. However, stem cell transplantation may stop the progression of ALD if done when neurological symptoms first appear. […] Doctors will focus on relieving your symptoms and slowing disease progression. […] In a recent clinical trial, boys with early-stage cerebral ALD were treated with gene therapy as an alternative to stem cell transplantation. Early results from gene therapy are promising. Disease progression stabilized in 88 percent of boys who participated in the trial.

• #74 Adrenoleukodystrophy – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK562328/

  Adrenoleukodystrophy is a rare genetic peroxisomal disorder characterized by the abnormal metabolism of very long-chain fatty acids (VLCFAs) due to mutations in the ABCD1 gene. This leads to the accumulation of VLCFAs, particularly affecting the brain, spinal cord, adrenal glands, and testes. […] Symptoms typically include progressive neurological dysfunction and adrenal insufficiency, which is managed with glucocorticoid and mineralocorticoid replacement therapies. Hematopoietic stem cell transplantation (HSCT) remains the primary therapeutic option for early-stage adrenoleukodystrophy, offering the best chance to halt disease progression and improve outcomes. […] Clinical manifestations of adrenoleukodystrophy vary widely but usually include the combination of progressive neurological dysfunction and adrenal insufficiency.

• #75 Adrenoleukodystrophy | Baby’s First Test | Newborn Screening | Baby Health

  https://www.babysfirsttest.org/newborn-screening/conditions/adrenoleukodystrophy

  Boys with childhood cerebral ALD (cALD) usually start showing symptoms when they are between 4 and 10 years old. Symptoms start with attention deficit disorder/hyperactivity and then progress to the symptoms listed under condition characteristics. The condition progresses very quickly, and the child usually passes away a few years after symptoms first appear, although some with intensive medical treatment may survive longer. […] Children with childhood cerebral ALD (cALD) will have ongoing neurological deterioration. Unless HCT (stem cell bone marrow transplantation) is done early, the child will continue to lose neurologic abilities. Sadly without HCT, most children with cALD will die before age ten. The best results from HCT are seen if the transplant is performed when the beginning changes to the brain are detected by MRI but before physical symptoms are seen. […] The other forms of ALD are milder, and will progress over decades. AMN may result in early death due to nervous system deterioration, but Addison disease can be managed through regular testing and treatment with replacement corticosteroid.

• #76 Adrenoleukodystrophy – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/adrenoleukodystrophy/diagnosis-treatment/drc-20369160

  To diagnose ALD, your doctor will review your symptoms and your medical and family history. […] Adrenoleukodystrophy has no cure. However, stem cell transplantation may stop the progression of ALD if done when neurological symptoms first appear. […] Doctors will focus on relieving your symptoms and slowing disease progression. […] In a recent clinical trial, boys with early-stage cerebral ALD were treated with gene therapy as an alternative to stem cell transplantation. Early results from gene therapy are promising. Disease progression stabilized in 88 percent of boys who participated in the trial.

• #77 New drug candidate slows the progression of adrenoleukodystrophy

  https://medicalxpress.com/news/2023-01-drug-candidate-adrenoleukodystrophy.html

  At the end of ADVANCE phase II/III, the researchers found that taking leriglitazone daily reduced the progression of certain key symptoms—such as gait imbalance—and, remarkably, decreased the risk of cALD, the acute cerebral form of the disease associated with premature death. Only subjects in the placebo group developed cALD, suggesting a protective effect of the drug. […] The study is now in an extension phase to confirm the ability of the molecule to delay the evolution of the disease. In addition, Professor Mochel’s team is treating a dozen adults with cALD on a compassionate basis and has observed a stabilization, sometimes even a regression, of brain lesions in these patients.

• #78 Adrenoleukodystrophy – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK562328/

  Adrenoleukodystrophy is a rare genetic peroxisomal disorder characterized by the abnormal metabolism of very long-chain fatty acids (VLCFAs) due to mutations in the ABCD1 gene. This leads to the accumulation of VLCFAs, particularly affecting the brain, spinal cord, adrenal glands, and testes. […] Symptoms typically include progressive neurological dysfunction and adrenal insufficiency, which is managed with glucocorticoid and mineralocorticoid replacement therapies. Hematopoietic stem cell transplantation (HSCT) remains the primary therapeutic option for early-stage adrenoleukodystrophy, offering the best chance to halt disease progression and improve outcomes. […] Clinical manifestations of adrenoleukodystrophy vary widely but usually include the combination of progressive neurological dysfunction and adrenal insufficiency.

• #79 Understanding Adrenoleukodystrophy: Symptoms, Causes, and Treatment Options | Medanta

  https://www.medanta.org/patient-education-blog/adrenoleukodystrophy-what-you-need-to-know-about-this-rare-genetic-disorder

  The treatment for Adrenoleukodystrophy (ALD) depends on the type and severity of the disease. In the early stages, adrenal insufficiency is treated with hormone replacement therapy. Treatment may also include Lorenzo’s oil, a mixture of fatty acids that may slow the progression of the disease in some patients. In advanced stages, bone marrow or stem cell transplants may be considered to replace damaged cells with healthy ones. Symptomatic treatments such as physical therapy, occupational therapy, and speech therapy may also be used to manage symptoms and improve quality of life. In some cases, medications may be prescribed to manage seizures or other symptoms. However, there is currently no cure for ALD, and treatment is primarily focused on managing symptoms and slowing disease progression. […] Early infancy is a common time for symptoms to appear as youngsters begin to lose their prior skills. Speak with your healthcare professional if your child exhibits behavioral problems or starts to decline in other areas. The likelihood of slowing ALD increases with the timing of therapy.

• #80 Understanding Adrenoleukodystrophy: Symptoms, Causes, and Treatment Options | Medanta

  https://www.medanta.org/patient-education-blog/adrenoleukodystrophy-what-you-need-to-know-about-this-rare-genetic-disorder

  The treatment for Adrenoleukodystrophy (ALD) depends on the type and severity of the disease. In the early stages, adrenal insufficiency is treated with hormone replacement therapy. Treatment may also include Lorenzo’s oil, a mixture of fatty acids that may slow the progression of the disease in some patients. In advanced stages, bone marrow or stem cell transplants may be considered to replace damaged cells with healthy ones. Symptomatic treatments such as physical therapy, occupational therapy, and speech therapy may also be used to manage symptoms and improve quality of life. In some cases, medications may be prescribed to manage seizures or other symptoms. However, there is currently no cure for ALD, and treatment is primarily focused on managing symptoms and slowing disease progression. […] Early infancy is a common time for symptoms to appear as youngsters begin to lose their prior skills. Speak with your healthcare professional if your child exhibits behavioral problems or starts to decline in other areas. The likelihood of slowing ALD increases with the timing of therapy.

• #81 Our Focus: Cerebral Adrenoleukodystrophy (CALD) | bluebird bio

  https://www.bluebirdbio.com/our-focus/cerebral-adrenoleukodystrophy

  CALD is a progressive, irreversible, and fatal disease primarily affecting young children. […] The disease results in rapid loss of neurological function after the initial onset of symptoms and sadly, nearly half of patients who do not receive treatment die within five years of symptom onset. […] For many boys, adrenal insufficiency or behavioral problems are the first detected symptoms, preceding the onset of neurologic symptoms. As the disease progresses, boys develop vision and hearing problems, seizures, poor coordination, and difficulty swallowing. […] CALD results in rapid loss of function in untreated patients. […] In untreated patients, MFDs can progress rapidly, and have a catastrophic impact on basic functions: loss of communication, cortical blindness, tube feeding, total incontinence, wheelchair dependence, complete loss of voluntary movement. […] Diagnosing and treating CALD as early as possible is essential to give these children the best possible chance at life by stopping disease progression and preserving neurological function.

• #82 Adrenoleukodystrophy – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK562328/

  Adrenomyeloneuropathy is a milder spectrum of X-ALD. The typical age at presentation is usually in the third decade of life for men and post-menopausal for women, with initial symptoms often involving spinal cord dysfunction. […] Most men who survive until adulthood have the adrenomyeloneuropathy form of adrenoleukodystrophy. This form is characterized by a chronic progressive axonopathy affecting the sensory and motor spinal cord tracts, leading to progressive spastic paraparesis, peripheral neuropathy, bowel and bladder sphincter dysfunction, and sexual dysfunction, sometimes accompanied by adrenal insufficiency. […] The prognosis for neonatal adrenoleukodystrophy and most forms of X-ALD is generally poor. However, patients with adrenomyeloneuropathy can survive past age 65, although often with significant morbidity.

• #83 Adrenoleukodystrophy

  https://www.brainfacts.org/diseases-and-disorders/neurological-disorders-az/diseases-a-to-z-from-ninds/adrenoleukodystrophy

  X-linked Adrenoleukodystrophy (ALD) is one of a group of genetic disorders called the leukodystrophies that cause damage to the myelin sheath, an insulating membrane that surrounds nerve cells in the brain. The loss of myelin and the progressive dysfunction of the adrenal gland are the primary characteristics of X-ALD. While nearly all patients with X-ALD suffer from adrenal insufficiency, also known as Addison’s disease, the neurological symptoms can begin either in childhood or in adulthood. The childhood cerebral form is the most severe, with onset between ages 4 and 10. The most common symptoms are usually behavioral changes such as abnormal withdrawal or aggression, poor memory, and poor school performance. Other symptoms include visual loss, learning disabilities, seizures, poorly articulated speech, difficulty swallowing, deafness, disturbances of gait and coordination, fatigue, intermittent vomiting, increased skin pigmentation, and progressive dementia. The milder adult-onset form is also known as adrenomyeloneuropathy (AMN), which typically begins between ages 21 and 35. Symptoms may include progressive stiffness, weakness or paralysis of the lower limbs, and ataxia. Although adult-onset ALD progresses more slowly than the classic childhood form, it can also result in deterioration of brain function. […] Prognosis for patients with childhood cerebral X-ALD is generally poor due to progressive neurological deterioration unless bone marrow transplantation is performed early. Death usually occurs within 1 to 10 years after the onset of symptoms. Adult-onset AMN will progress over decades.

• #84 Adrenoleukodystrophy – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK562328/

  Adrenomyeloneuropathy is a milder spectrum of X-ALD. The typical age at presentation is usually in the third decade of life for men and post-menopausal for women, with initial symptoms often involving spinal cord dysfunction. […] Most men who survive until adulthood have the adrenomyeloneuropathy form of adrenoleukodystrophy. This form is characterized by a chronic progressive axonopathy affecting the sensory and motor spinal cord tracts, leading to progressive spastic paraparesis, peripheral neuropathy, bowel and bladder sphincter dysfunction, and sexual dysfunction, sometimes accompanied by adrenal insufficiency. […] The prognosis for neonatal adrenoleukodystrophy and most forms of X-ALD is generally poor. However, patients with adrenomyeloneuropathy can survive past age 65, although often with significant morbidity.

• #85 Adrenoleukodystrophy

  https://www.brainfacts.org/diseases-and-disorders/neurological-disorders-az/diseases-a-to-z-from-ninds/adrenoleukodystrophy

  X-linked Adrenoleukodystrophy (ALD) is one of a group of genetic disorders called the leukodystrophies that cause damage to the myelin sheath, an insulating membrane that surrounds nerve cells in the brain. The loss of myelin and the progressive dysfunction of the adrenal gland are the primary characteristics of X-ALD. While nearly all patients with X-ALD suffer from adrenal insufficiency, also known as Addison’s disease, the neurological symptoms can begin either in childhood or in adulthood. The childhood cerebral form is the most severe, with onset between ages 4 and 10. The most common symptoms are usually behavioral changes such as abnormal withdrawal or aggression, poor memory, and poor school performance. Other symptoms include visual loss, learning disabilities, seizures, poorly articulated speech, difficulty swallowing, deafness, disturbances of gait and coordination, fatigue, intermittent vomiting, increased skin pigmentation, and progressive dementia. The milder adult-onset form is also known as adrenomyeloneuropathy (AMN), which typically begins between ages 21 and 35. Symptoms may include progressive stiffness, weakness or paralysis of the lower limbs, and ataxia. Although adult-onset ALD progresses more slowly than the classic childhood form, it can also result in deterioration of brain function. […] Prognosis for patients with childhood cerebral X-ALD is generally poor due to progressive neurological deterioration unless bone marrow transplantation is performed early. Death usually occurs within 1 to 10 years after the onset of symptoms. Adult-onset AMN will progress over decades.

• #86 Adrenoleukodystrophy / Adrenomyeloneuropathy – National Adrenal Diseases Foundation

  https://www.nadf.us/adrenoleukodystrophy-adrenomyeloneuropathy.html

  The age of onset for adrenomyeloneuropathy is typically early adulthood, but can be later. Symptoms include leg stiffness and weakness, genitourinary tract disorders, and behavior changes. Addisons disease is common in AMN. […] The ADDISONS DISEASE ONLY form presents anytime from early childhood through adult life with non-specific symptoms and signs of weakness, weight loss and failure to thrive, skin darkening, vomiting, and shock. Lifelong replacement hormones (usually oral glucocorticoids and mineralocorticoids) are required in such cases, and will usually prevent episodes of acute adrenal insufficiency. […] Life expectancy depends on the severity of the signs and symptoms, timing of the diagnosis and treatment for adrenal insufficiency.

• #87 Orphanet: X-linked adrenoleukodystrophy

  https://www.orpha.net/en/disease/detail/43

  About 90% develop a myelopathy and peripheral neuropathy, but at a later age (after 40 years of age) and with slower progression (over decades) than in males. […] There is currently no treatment to prevent the occurrence or progression of the myelopathy. However, with appropriate supportive care life expectancy is near normal.

• #88 Adrenoleukodystrophy | Children’s Hospital of Philadelphia

  https://www.chop.edu/conditions-diseases/adrenoleukodystrophy

  As the disease progresses, symptoms include visual disturbances, loss of hearing, seizures, and trouble moving or speaking, eventually leading to loss of all body functions over a few years. […] Every child identified with ALD through the newborn screening must receive standardized neurologic monitoring throughout childhood that includes blood work and brain MRIs. This allows clinicians to see changes in the brain before the child shows any physical symptoms. This also allows treatment of adrenal insufficiency, which can be life threatening. If the care team sees anything concerning, they can provide personalized intervention immediately before a child has permanent injury to their brain. Targeted treatment of CALD has the best outcome when performed on an individual before symptoms are clinically visible. […] In recent clinical trials, gene therapy has shown promising results in stabilizing the progression of the disease in boys with early-stage CALD. However, additional research is necessary to assess its long-term effectiveness and safety.

• #89 Clinical features, evaluation, and diagnosis of X-linked adrenoleukodystrophy – UpToDate

  https://www.uptodate.com/contents/clinical-features-evaluation-and-diagnosis-of-x-linked-adrenoleukodystrophy

  X-linked adrenoleukodystrophy (ALD; MIM #300100) is a peroxisomal disorder of beta-oxidation that results in accumulation of very long-chain fatty acids (VLCFAs) in all tissues. Patients with ALD are asymptomatic at birth, but during life, adrenal insufficiency, leukodystrophy, and myeloneuropathy occur. Specific disease manifestations and disease severity are highly variable among patients (table 1) […] It is more correct to describe ALD as a progressive neurometabolic disorder with symptoms that accumulate during life. Symptoms can be classified into specific clinical syndromes: leukodystrophy, myeloneuropathy, and adrenal insufficiency.

• #90 Adrenoleukodystrophy – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/adrenoleukodystrophy/diagnosis-treatment/drc-20369160

  To diagnose ALD, your doctor will review your symptoms and your medical and family history. […] Adrenoleukodystrophy has no cure. However, stem cell transplantation may stop the progression of ALD if done when neurological symptoms first appear. […] Doctors will focus on relieving your symptoms and slowing disease progression. […] In a recent clinical trial, boys with early-stage cerebral ALD were treated with gene therapy as an alternative to stem cell transplantation. Early results from gene therapy are promising. Disease progression stabilized in 88 percent of boys who participated in the trial.

• #91 New drug candidate slows the progression of adrenoleukodystrophy

  https://medicalxpress.com/news/2023-01-drug-candidate-adrenoleukodystrophy.html

  At the end of ADVANCE phase II/III, the researchers found that taking leriglitazone daily reduced the progression of certain key symptoms—such as gait imbalance—and, remarkably, decreased the risk of cALD, the acute cerebral form of the disease associated with premature death. Only subjects in the placebo group developed cALD, suggesting a protective effect of the drug. […] The study is now in an extension phase to confirm the ability of the molecule to delay the evolution of the disease. In addition, Professor Mochel’s team is treating a dozen adults with cALD on a compassionate basis and has observed a stabilization, sometimes even a regression, of brain lesions in these patients.

Zobacz więcej